Zusammenfassung
Häufigkeit: Obwohl mit etwa 1–2% eine vergleichsweise seltene maligne Erkrankung in den USA, ist es mit 20–30% das häufigste Malignom in Teilen von Asien und Afrika
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
American Joint Committee on Cancer (1992) Liver (including intrahepatic bile ducts). In: Beahrs OH, Henson DE, Hutter RVP, Kennedy BJ (eds) Manual for staging of cancer. Lippincott, Philadelphia, pp 89–90
Beghiti J, Panis Y, Farges et al. (1991) Intrahepatic recurrence after resection of hepatocellular carcinoma complicating cirrhosis. Ann Surg 241: 114–117
Carr BI (1992) High objective response rates of advanced hepatocellular carcinoma to intraarterial chemotherapy. Proc ASCO 11: 470
Colombo M (1992) Hepatocellular carcinoma. J Hepatol 15: 225–236
Farmer DG, Rosove MH, Shaked A, Busuttil RW (1994) Current treatment modalities for hepatocellular carcinoma. Ann Surg 219: 236–247
Franco D, Capussotti L, Smadja C et al. (1990) Resection of hepatocellular carcinoma. Gastroenterology 98: 733–738
Gastrointestinal Tumor Study Group (1990) A prospective trial of recombinant human interferon alpha 2b in previously untreated patients with hepatocellular carcinoma. Cancer 66: 135–139
Hochster HS, Green MD, Speyer S (1985) 4-Epidoxorubicin (epirubicin) activity in hepatocellular carcinoma. J Clin Oncol 3: 1525–1540
Ikeda K, Saitoh S, Tsubota A et al. (1993) Risk factor for tumor recurrence and prognosis after curative resection of hepatocellular carcinoma. Cancer 71: 19–25
Iwatsuki S, Starzl TE, Sheahan DA (1991) Hepatic resections versus transplantation for hepatocellular carcinoma. Ann Surg 214: 221–229
Lotze MT, Flickinger JC, Carr BI (1993) Hepatobiliary neoplasms. In: DeVita VT, Hellman S, Rosenberg (eds) Cancer principles and practice of oncology. Lippincott, Philadelphia, pp 883–900
Nagorney DM, Van Heerden JA, Illstrup DM, Adson MA (1989) Primary hepatic malignancy: Surgical management and determinants of survical. Surgery 106: 740–749
Okuda K, Ohtsuki T, Obata H (1985) Natural history of hepatocellular carcinoma and prognosis in relation to treatment: Study of 850 Patients. Cancer 56: 918–928
Okuda K (1992) Hepatocellular carcinoma: recent progress. Hepatology 15: 948–963
Pichlmayr R, Weimann A, Steinhoff G, Ringe B (1992) Liver transplantation for hepatocellular carcinoma: clinical results and future aspects. Cancer Chemother Pharmacol 31 [suppl I]: 157–161
Stone MJ, Klintmalm G, Polter D et al. (1989) Neo-adjuvant chemotherapy and orthotopic liver transplantation for hepatocellular carcinoma. Transplantation 48: 344–347
Takayasu K, Moriyama N, Muramatsu Y et al. (1990) The diagnosis of small hepatocellular carcinomas: efficiency of various imaging procedures in 100 patients. Am J Radiol 155: 49–54
Tanaka K, Nakamura S, Numata K et al. (1992) Hepatocellular carcinoma: treatment with percutaneous ethanol injection and transcatheter arterial embolization. Radiology 185: 457–460
Yamanaka N, Okamoto E, Foyasaka A (1990) Prognostic faktors after hepatectomy for hepatocellular carcinoma. Cancer 56: 1104–1110
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Strumberg, D., Wilke, H. (1997). Hepatozelluläres Karzinom. In: Schmoll, HJ., Höffken, K., Possinger, K. (eds) Kompendium Internistische Onkologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-12175-7_37
Download citation
DOI: https://doi.org/10.1007/978-3-662-12175-7_37
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-60830-1
Online ISBN: 978-3-662-12175-7
eBook Packages: Springer Book Archive